MILLER STRATEGIES, LLC

Lobbying for PFIZER INC. · pharmaceutical corporation

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $150,000.00 income · posted Jul 20, 2026

Lobbying activity 4

Medicare/Medicaid

Medicare and healthcare policy issues as they relate to drug pricing.

Health Issues

Issues related to 340B Program

Taxation/Internal Revenue Code

General issues with tax reform and foreign tax issues.

Labor Issues/Antitrust/Workplace

Issues related to drug consolidation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.